NCT03853798Phase 3Completed

Extension Study of AG-348 in Adult Participants With Pyruvate Kinase Deficiency Previously Enrolled in AG-348-006 or AG348-C-007

Study sponsor: Agios Pharmaceuticals, Inc. · AGIO

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2024-07-03Actual
Enrollment · participants90Actual
Source updated2025-11-18Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview